HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms

Virus Research

Volumn 167, Issue 2, 2012, Pages 273-284

  Kadeppagari, Ravi Kumar ^a   Sanchez, Rebecca L ^a,b   Foster, Timothy P ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Louisiana Vaccine Center   (United States)

Author keywords

Herpes simplex; Herpesvirus 2; Host pathogen interactions; Human; Immune evasion; Interferon type I; Stat2 transcription factor

Indexed keywords

INTERFERON; MESSENGER RNA; STAT2 PROTEIN; VIRUS DNA;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DNA REPLICATION; FIBROBLAST; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; IMMUNE EVASION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; RNA DEGRADATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS REPLICATION;

ANIMALS; CELL LINE; HERPESVIRUS 2, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERON TYPE I; SIGNAL TRANSDUCTION; STAT2 TRANSCRIPTION FACTOR;

HERPES; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 84863866575     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.05.010     Document Type: Article

References (77)

1. Akhtar L.N., Benveniste E.N. Viral exploitation of host SOCS protein functions. Journal of Virology 2011, 85(5):1912-1921.
2. Akhtar L.N., Qin H., Muldowney M.T., Yanagisawa L.L., Kutsch O., Clements J.E., Benveniste E.N. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. Journal of Immunology 2010, 185(4):2393-2404.
3. Bandyopadhyay S.K., Leonard G.T., Bandyopadhyay T., Stark G.R., Sen G.C. Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. Journal of Biological Chemistry 1995, 270(33):19624-19629.
4. Boutell C., Sadis S., Everett R.D. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. Journal of Virology 2002, 76(2):841-850.
5. Brukman A., Enquist L.W. Suppression of the interferon-mediated innate immune response by pseudorabies virus. Journal of Virology 2006, 80(13):6345-6356.
6. Cassady K.A., Gross M., Roizman B. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. Journal of Virology 1998, 72(11):8620-8626.
7. Chee A.V., Roizman B. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. Journal of Virology 2004, 78(8):4185-4196.
8. Chelbi-Alix M.K., de The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 1999, 18(4):935-941.
9. Chou J., Roizman B. Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(12):5247-5251.
10. Conrady C.D., Halford W.P., Carr D.J. Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection. Journal of Virology 2011, 85(4):1625-1633.
11. Darnell J.E. STATs and gene regulation. Science 1997, 277(5332):1630-1635.
12. Duerst R.J., Morrison L.A. Innate immunity to herpes simplex virus type 2. Viral Immunology 2003, 16(4):475-490.
13. Duerst R.J., Morrison L.A. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 2004, 322(1):158-167.
14. Elgadi M.M., Hayes C.E., Smiley J.R. The herpes simplex virus vhs protein induces endoribonucleolytic cleavage of target RNAs in cell extracts. Journal of Virology 1999, 73(9):7153-7164.
15. Esclatine A., Taddeo B., Evans L., Roizman B. The herpes simplex virus 1 UL41 gene-dependent destabilization of cellular RNAs is selective and may be sequence-specific. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(10):3603-3608.
16. Esclatine A., Taddeo B., Roizman B. The UL41 protein of herpes simplex virus mediates selective stabilization or degradation of cellular mRNAs. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(52):18165-18170.
17. Feng P., Everly D.N., Read G.S. mRNA decay during herpes simplex virus (HSV) infections: protein-protein interactions involving the HSV virion host shutoff protein and translation factors eIF4H and eIF4A. Journal of Virology 2005, 79(15):9651-9664.
18. Frey K.G., Ahmed C.M., Dabelic R., Jager L.D., Noon-Song E.N., Haider S.M., Johnson H.M., Bigley N.J. HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion. Journal of Immunology 2009, 183(2):1253-1262.
19. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nature Medicine 1999, 5(11):1249-1255.
20. Garcia-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312(5775):879-882.
21. Hagglund R., Roizman B. Characterization of the novel E3 ubiquitin ligase encoded in exon 3 of herpes simplex virus-1-infected cell protein 0. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(12):7889-7894.
22. Hagglund R., Van Sant C., Lopez P., Roizman B. Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(2):631-636.
23. Hahm B., Trifilo M.J., Zuniga E.I., Oldstone M.B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 2005, 22(2):247-257.
24. Halford W.P., Puschel R., Rakowski B. Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine. PLoS One 2010, 5(8):e12251.
25. Harle P., Sainz B., Carr D.J., Halford W.P. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology 2002, 293(2):295-304.
26. He B., Gross M., Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(3):843-848.
27. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434(7034):772-777.
28. Honess R.W., Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. Journal of Virology 1974, 14(1):8-19.
29. Honess R.W., Roizman B. Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proceedings of the National Academy of Sciences of the United States of America 1975, 72(4):1276-1280.
30. Horvath C.M. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. European Journal of Biochemistry 2004, 271(23-24):4621-4628.
31. Horvath C.M., Darnell J.E. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Current Opinion in Cell Biology 1997, 9(2):233-239.
32. Improta T., Schindler C., Horvath C.M., Kerr I.M., Stark G.R., Darnell J.E. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(11):4776-4780.
33. Johnson K.E., Knipe D.M. Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation. Virology 2010, 396(1):21-29.
34. Johnson K.E., Song B., Knipe D.M. Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology 2008, 374(2):487-494.
35. Kessler D.S., Veals S.A., Fu X.Y., Levy D.E. Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes and Development 1990, 4(10):1753-1765.
36. Khabar K.S., Young H.A. Post-transcriptional control of the interferon system. Biochimie 2007, 89(6-7):761-769.
37. Knopf C.W. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved. Journal of General Virology 1987, 68(Pt. 5):1429-1433.
38. Korom M., Wylie K.M., Morrison L.A. Selective ablation of virion host shutoff protein RNase activity attenuates herpes simplex virus 2 in mice. Journal of Virology 2008, 82(7):3642-3653.
39. Kramer M.J., Dennin R., Kramer C., Jones G., Connell E., Rolon N., Gruarin A., Kale R., Trown P.W. Cell and virus sensitivity studies with recombinant human alpha interferons. Journal of Interferon Research 1983, 3(4):425-435.
40. Lam Q., Smibert C.A., Koop K.E., Lavery C., Capone J.P., Weinheimer S.P., Smiley J.R. Herpes simplex virus VP16 rescues viral mRNA from destruction by the virion host shutoff function. EMBO Journal 1996, 15(10):2575-2581.
41. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., Tough D.F. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001, 14(4):461-470.
42. Le Bon A., Tough D.F. Links between innate and adaptive immunity via type I interferon. Current Opinion in Immunology 2002, 14(4):432-436.
43. Le V.T., Trilling M., Wilborn M., Hengel H., Zimmermann A. Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. Journal of General Virology 2008, 89(Pt. 10):2416-2426.
44. Lee C.K., Bluyssen H.A., Levy D.E. Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity. Journal of Biological Chemistry 1997, 272(35):21872-21877.
45. Leib D.A., Harrison T.E., Laslo K.M., Machalek M.A., Moorman N.J., Virgin H.W. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. Journal of Experimental Medicine 1999, 189(4):663-672.
46. Leib D.A., Machalek M.A., Williams B.R., Silverman R.H., Virgin H.W. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(11):6097-6101.
47. Levy D.E., Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine and Growth Factor Reviews 2001, 12(2-3):143-156.
48. Melroe G.T., DeLuca N.A., Knipe D.M. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. Journal of Virology 2004, 78(16):8411-8420.
49. Mossman K.L., Saffran H.A., Smiley J.R. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. Journal of Virology 2000, 74(4):2052-2056.
50. Mossman K.L., Smiley J.R. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. Journal of Virology 2002, 76(4):1995-1998.
51. Mott K.R., Underhill D., Wechsler S.L., Town T., Ghiasi H. A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages. Virology Journal 2009, 6:56.
52. Murphy J.A., Duerst R.J., Smith T.J., Morrison L.A. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. Journal of Virology 2003, 77(17):9337-9345.
53. Narita M., Ando Y., Soushi S., Kurata T., Arao Y. The BglII-N fragment of herpes simplex virus type 2 contains a region responsible for resistance to antiviral effects of interferon. Journal of General Virology 1998, 79(Pt. 3):565-572.
54. Paladino P., Collins S.E., Mossman K.L. Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS One 2010, 5(4):e10428.
55. Paladino P., Mossman K.L. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. Journal of Interferon and Cytokine Research 2009, 29(9):599-607.
56. Parisien J.P., Lau J.F., Horvath C.M. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. Journal of Virology 2002, 76(13):6435-6441.
57. Parisien J.P., Lau J.F., Rodriguez J.J., Sullivan B.M., Moscona A., Parks G.D., Lamb R.A., Horvath C.M. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 2001, 283(2):230-239.
58. Parisien J.P., Lau J.F., Rodriguez J.J., Ulane C.M., Horvath C.M. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. Journal of Virology 2002, 76(9):4190-4198.
59. Pasieka T.J., Baas T., Carter V.S., Proll S.C., Katze M.G., Leib D.A. Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response. Journal of Virology 2006, 80(15):7600-7612.
60. Pasieka T.J., Lu B., Leib D.A. Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1. Journal of Virology 2008, 82(12):6052-6055.
61. Peng T., Zhu J., Klock A., Phasouk K., Huang M.L., Koelle D.M., Wald A., Corey L. Evasion of the mucosal innate immune system by herpes simplex virus type 2. Journal of Virology 2009, 83(23):12559-12568.
62. Pierce A.T., DeSalvo J., Foster T.P., Kosinski A., Weller S.K., Halford W.P. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. Journal of General Virology 2005, 86(Pt. 9):2421-2432.
63. Platanias L.C., Fish E.N. Signaling pathways activated by interferons. Experimental Hematology 1999, 27(11):1583-1592.
64. Platanias L.C., Uddin S., Colamonici O.R. Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. Journal of Biological Chemistry 1994, 269(27):17761-17764.
65. Roizman B., Kozak M., Honess R.W., Hayward G. Regulation of herpesvirus macromolecular synthesis: evidence for multilevel regulation of herpes simplex 1 RNA and protein synthesis. Cold Spring Harbor Symposia on Quantitative Biology 1975, (39 Pt. 2):687-701.
66. Samuel C.E. Antiviral actions of interferons. Clinical Microbiology Reviews 2001, 14(4):778-809. (table of contents).
67. Sanchez R.L., Ramsay A.J., Foster T.P. Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopes. Journal of Virological Methods 2012, 179(1):116-126.
68. Schindler C., Fu X.Y., Improta T., Aebersold R., Darnell J.E. Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(16):7836-7839.
69. Smibert C.A., Popova B., Xiao P., Capone J.P., Smiley J.R. Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs. Journal of Virology 1994, 68(4):2339-2346.
70. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annual Review of Biochemistry 1998, 67:227-264.
71. Su Y.H., Oakes J.E., Lausch R.N. Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon alpha/beta. Journal of General Virology 1993, 74(Pt. 11):2325-2332.
72. Taddeo B., Esclatine A., Roizman B. Post-transcriptional processing of cellular RNAs in herpes simplex virus-infected cells. Biochemical Society Transactions 2004, 32(Pt. 5):697-701.
73. Uddin S., Chamdin A., Platanias L.C. Interaction of the transcriptional activator Stat-2 with the type I interferon receptor. Journal of Biological Chemistry 1995, 270(42):24627-24630.
74. Ulane C.M., Horvath C.M. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 2002, 304(2):160-166.
75. Yokota S., Yokosawa N., Kubota T., Suzutani T., Yoshida I., Miura S., Jimbow K., Fujii N. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology 2001, 286(1):119-124.
76. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., Fujii N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication. Virology 2005, 338(1):173-181.
77. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., Miura S., Jimbow K., Fujii N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. Journal of Virology 2004, 78(12):6282-6286.